Aspartoacylase (ASPA) Peptide
-
- Target See all ASPA products
- ASPA (Aspartoacylase (ASPA))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- IKTSLAPLPC YVYLIEHPSL KYATTRSIAK YPVGIEVGPQ PQGVLRADIL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ASPA antibody,
Alternative Names: ASPA control peptide, ASPA antibody Blocking Peptide, Anti-ASPA Blocking Peptide, Aspartoacylase Blocking Peptide, Canavan Disease Blocking Peptide, ACY2 Blocking Peptide, ASP Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- ASPA (Aspartoacylase (ASPA))
- Synonyms
- asp Peptide, acy2 Peptide, ACY-2 Peptide, ASP Peptide, ACY2 Peptide, Acy-2 Peptide, Acy2 Peptide, nur7 Peptide, zgc:171507 Peptide, aspartoacylase Peptide, Aspartoacylase Peptide, ASPA Peptide, aspa Peptide, Fbal_2465 Peptide, Aspa Peptide
- Background
- ASPA catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter. In other tissues it acts as a scavenger of NAA from body fluids.
- Molecular Weight
- 36 kDa
-